Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Javed

Showing results (341-350 of 392) with videos related to

Pageof 40
Sort By:
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Gastroenterology|April 29, 2015
Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse ModelsLi Wen, Svetlana Voronina, Muhammad A Javed, et al.
The American Journal of Pathology|October 18, 2015
Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation ProgramsJohn F Eisses, Angela Criscimanna, Zachary R Dionise, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Surgery|May 22, 2026
Postpancreatectomy liver injury: A relevant entity in the modern era of pancreatic cancer surgery with hepatic vessel resection. A monocentric retrospective cohort studyAlessio Marchetti, Camila H Salinas, Jonathan Garnier, et al.
Annals of Surgical Oncology|January 4, 2025
ASO Visual Abstract: Defining and Predicting Early Recurrence for Optimal Treatment Strategies in Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer--An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Annals of Surgical Oncology|December 12, 2024
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Pageof 40

Showing results (341-350 of 392) with videos related to

Sort By:
Pageof 40
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Gastroenterology|April 29, 2015
Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse ModelsLi Wen, Svetlana Voronina, Muhammad A Javed, et al.
The American Journal of Pathology|October 18, 2015
Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation ProgramsJohn F Eisses, Angela Criscimanna, Zachary R Dionise, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Surgery|May 22, 2026
Postpancreatectomy liver injury: A relevant entity in the modern era of pancreatic cancer surgery with hepatic vessel resection. A monocentric retrospective cohort studyAlessio Marchetti, Camila H Salinas, Jonathan Garnier, et al.
Annals of Surgical Oncology|January 4, 2025
ASO Visual Abstract: Defining and Predicting Early Recurrence for Optimal Treatment Strategies in Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer--An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Annals of Surgical Oncology|December 12, 2024
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Pageof 40